Purchase of 3,700 shares at $0.055 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Oct 6, 2026 · Disclosed Oct 6, 2026
Source: SEC Form 4 · 0001035422-26-000016 · filed 2026-10-06 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)." Disclosed 2026-10-06. https://desqlong.com/cards/0001035422-26-000016-1 (retrieved 2026-10-07).